(4.9) HTN PHARMACOLOGY
19 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism of action of diuretics in treating hypertension?

  • Blocking angiotensin II receptors
  • Inhibition of calcium channel entry into cells
  • Reduction of blood volume through increased urine output (correct)
  • Inhibition of angiotensin-converting enzyme
  • Which of the following is a common adverse effect associated with ACE inhibitors?

  • Cough (correct)
  • Bradycardia
  • Peripheral edema
  • Nausea
  • Calcium channel blockers primarily cause vasodilation by which mechanism?

  • Preventing calcium from entering vascular smooth muscle cells (correct)
  • Blocking the sympathetic nervous system
  • Inhibiting the enzyme that produces angiotensin II
  • Increasing renal blood flow
  • The mechanism of action of angiotensin receptor blockers (ARBs) is best described as:

    <p>Blocking the effects of angiotensin II at its receptor sites</p> Signup and view all the answers

    Which class of antihypertensive medications is known for causing peripheral edema as a common side effect?

    <p>Calcium channel blockers</p> Signup and view all the answers

    How do diuretics directly impact blood pressure physiology?

    <p>By reducing plasma volume</p> Signup and view all the answers

    Which antihypertensive drug class requires monitoring for potassium levels due to the risk of hyperkalemia?

    <p>ACE inhibitors</p> Signup and view all the answers

    Which antihypertensive agent is categorized as a calcium channel blocker?

    <p>Amlodipine</p> Signup and view all the answers

    In the context of hypertension, what physiological change is primarily targeted by ARBs?

    <p>Effects of angiotensin II on blood vessels</p> Signup and view all the answers

    Adverse effects associated with calcium channel blockers are most closely linked to their impact on which body system?

    <p>Cardiovascular system</p> Signup and view all the answers

    What is the primary mechanism of action of ACE inhibitors in treating hypertension?

    <p>Preventing the conversion of angiotensin I to angiotensin II</p> Signup and view all the answers

    Which of the following adverse effects is commonly associated with ACE inhibitors?

    <p>Dry cough</p> Signup and view all the answers

    What differentiates Angiotensin Receptor Blockers (ARBs) from ACE inhibitors?

    <p>ARBs do not cause a dry cough</p> Signup and view all the answers

    Calcium Channel Blockers primarily function by:

    <p>Limiting intracellular calcium to induce vasodilation</p> Signup and view all the answers

    Which of the following patients is most likely to benefit from ACE inhibitors?

    <p>A patient with a history of myocardial infarction</p> Signup and view all the answers

    Which of the following best describes the role of Aliskiren in hypertension management?

    <p>It blocks the activity of renin</p> Signup and view all the answers

    Which of the following best describes a common side effect of beta blockers used in hypertension treatment?

    <p>Erectile dysfunction</p> Signup and view all the answers

    What is the function of thiazide diuretics in managing hypertension?

    <p>Decreasing blood volume</p> Signup and view all the answers

    Which statement is true regarding angiotensin receptor blockers (ARBs)?

    <p>ARBs offer greater complete blockade of angiotensin II effects compared to ACE inhibitors</p> Signup and view all the answers

    Study Notes

    Hypertension Pharmacology Lecture Notes

    • Lecture #32: Hypertension Pharmacology, taught by Julia Hum, PhD
    • Course Time: Monday/Wednesday/Friday, 2:00-2:50 pm
    • Office Hours: Monday/Wednesday/Friday, 11:00 am-12:00 pm (317B or WebEx)
    • Course Website: marian.edu/medicalschool

    Learning Objectives (L32)

    • Objective 1: Compare and contrast the mechanisms of action (MOA) of the main classes of antihypertensive drugs (diuretics, RAAS inhibitors, calcium channel blockers).
    • Objective 2: Correlate the MOA of antihypertensive drugs to the underlying physiology of blood pressure.
    • Objective 3: Connect key adverse effects of antihypertensive drugs to their MOA and impact on vascular physiology.

    Take Home Slide (L32)

    • The diagram illustrates the renin-angiotensin-aldosterone system (RAAS) and its regulation of blood pressure.
    • Key components of the RAAS are angiotensinogen, renin, angiotensin I, angiotensin II, and aldosterone.
    • Renin inhibitors, ACE inhibitors, and ARBs (angiotensin receptor blockers) all target different steps in the RAAS to decrease blood pressure.
    • Aldosterone receptor antagonists also decrease blood pressure by blocking the effects of aldosterone.

    Top 10 List of Drugs Prescribed in America

    • This list presented common drugs prescribed in the US, including their indications. The specific top 10 list is included.

    Summary of Antihypertensive Drugs

    • This table details various types of antihypertensive drugs, including their classifications. -Angiotensin II Receptor Blockers -Beta-Blockers -Calcium Channel Blockers -ACE Inhibitors -Diuretics -Renin Inhibitors

    Drug Class Mechanisms for Treating Hypertension (LO1)

    • This section addresses the mechanisms by which different drug classes lower blood pressure.

    Hypertension Treatment Strategies (LO1)

    • Goal: Reduce cardiovascular and renal morbidity and mortality.
    • Current Recommendations:
      • Initially treat with a single antihypertensive drug (thiazide diuretic, ACE inhibitor, ARB, or calcium channel blocker) if blood pressure is above 130/90 mmHg.
      • If blood pressure remains uncontrolled, add additional medications selected to minimize adverse effects.
      • If blood pressure is greater than 160/100 mmHg, dual therapy should be initiated.

    Hypertension Management - IRL

    • This section shows a decision tree (algorithm). The decision-making process for treating hypertension in various patient populations is outlined, based on age, diabetes, CKD, and race.
    • Lifestyle interventions are to be used throughout the process

    Treatment of hypertension with concomitant diseases (FYI)

    • This table displays the recommended drug classes for use in patients with hypertension and various concomitant diseases. -High Coronary Disease Risk -Diabetes -Recurrent Stroke -Heart Failure -Previous Myocardial Infarction -Chronic Renal Disease

    Hypertension: Diuretics (LO1)

    • Goal: Decrease blood volume to decrease blood pressure.
    • Low-dose Diuretics: Safe, inexpensive, and effective in preventing stroke, myocardial infarction, and heart failure.
    • Monitoring: Routine electrolyte monitoring is recommended for patients taking diuretics.

    Hypertension: β-Blockers (LO1,2)

    • Mechanism of Action (MOA): Decrease cardiac output by blocking beta-adrenergic receptors and inhibiting renin release from the kidneys, which decreases angiotensin II and aldosterone secretion.
    • Prototype: Propranolol acts on both β₁ and β₂ receptors; Metoprolol and atenolol are selective β₁ blockers.
    • Adverse Effects: Bradycardia, hypotension, CNS effects (fatigue, lethargy, and insomnia), reduced libido, and erectile dysfunction reduced patient compliance.

    Hypertension: Renin Inhibitors (LO1,2)

    • Aliskiren: Inhibits renin, acting earlier in the RAAS than ACE inhibitors or ARBs.
    • Lowering BP: Lowers blood pressure about as effectively as ACE inhibitors, ARBs, or thiazides.

    Inhibitors of RAAS - Inhibitor of enzymatic activity of renin (LO1,2,3)

    • Aliskiren inhibits the enzymatic activity of renin, decreasing angiotensin II production and blood pressure. It is metabolized by CYP 3A4.
    • This inhibitor is effective in treating hypertension and may slow the progression of heart failure. Warnings exist regarding administration with other drugs (ACE inhibitors, ARBs) due to potential kidney complication and blood potassium issues.

    Hypertension: ACE Inhibitors (LO1,2)

    • First-line Treatment: Recommended as first-line therapy in patients at high risk of coronary disease or with a history of diabetes, stroke, heart failure, myocardial infarction, or chronic kidney disease
    • Mechanism of Action: The drugs inhibit the angiotensin-converting enzyme, decreasing angiotensin II production and vasodilation. This results in lowering blood pressure and reducing peripheral resistances.

    Inhibitors of RAAS - Angiotensin-converting enzyme inhibitors (LO1,2)

    • ACE inhibitors block the angiotensin-converting enzyme (ACE), preventing the conversion of angiotensin I to potent vasoconstrictor angiotensin II, resulting in vasodilation.
    • ACE inhibitors also decrease aldosterone secretion, which reduces sodium and water retention and contributes to lower blood pressure.
    • Drugs ending with "-pril" are part of this class. Lisinopril is a common example.

    Adverse Effects: ACE Inhibitors (LO3)

    • Dry Cough: A common side effect, thought to be due to increased bradykinin levels.
    • Hyperkalemia (High Potassium): Possible side effect that may increase the risk of kidney complications.
    • Angioedema: A rare but serious side effect, potentially life-threatening.

    Hypertension: ARBs (LO1,2)

    • Mechanism of Action (MOA): Block the angiotensin II receptors, decreasing the activation of AT1 receptors, preventing angiotensin II from stimulating vasoconstriction and aldosterone secretion.
    • Similar Benefits: Similar to ACE inhibitors - lowering blood pressure through reducing peripheral resistance. Reduces salt and water retention via decreased aldosterone stimulation.
    • Examples: Valsartan, losartan, etc. are "-sartan" ending drugs.

    Inhibitors of RAAS - Angiotensin Receptor Blockers (LO1,2)

    • ARBs are competitive antagonists of angiotensin II type 1 receptors.
    • These drugs block the action of angiotensin II, thus reducing vasoconstriction and aldosterone secretion.
    • Clinically, ARBs are substitutes for ACE inhibitors. The adverse effects are similar to ACE inhibitors; however, the cough component is typically absent.

    Calcium Channel Blockers (LO1,2)

    • Mechanism of Action (MOA): Limit intracellular calcium, promoting vasodilation of arterioles, by blocking the inward movement of calcium through L-type calcium channels in smooth muscle cells.
    • This leads to a reduction in peripheral resistance and decreased blood pressure.
    • Different Classes: Divided into three structural classes: Diphenylalkylamines (Verapamil), Benzothiazepines (Diltiazem), and Dihydropyridines (Nifedipine).

    Adverse Effects: Calcium Channel Blockers (LO3)

    • Heart Failure: Verapamil and Diltiazem may be problematic for patients with heart failure and should be avoided.
    • Side Effects: Dizziness, headache, fatigue (from the reduction in blood pressure); Peripheral Edema.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz focuses on the pharmacological mechanisms of antihypertensive drugs, including diuretics, RAAS inhibitors, and calcium channel blockers. It aims to enhance your understanding of their action, relation to blood pressure physiology, and potential adverse effects. Test your knowledge and connect these concepts with real physiological outcomes.

    More Like This

    Use Quizgecko on...
    Browser
    Browser